M.B.A. van Doorn
Erasmus University Rotterdam
Internal medicineEndocrinologySurgeryDermatologyCardiologyPhysical exercisePhysical therapyAdverse effectMedDRAInfliximabEtanerceptLentigo malignaHeart rateResponse rate (survey)NoseDiscontinuationImmune-mediated inflammatory diseasesPregnancyMEDLINEAdalimumabAdverse drug reactionPsoriasisHutchinson's Melanotic FreckleNose neoplasmIndependent researchDrug reactionIn patientRheumatic diseaseGestationFamily medicinePhysical examinationClinical trialMedicineBiology
28Publications
7H-index
273Citations
Publications 28
Newest
Source
#1F. R. KasiemH-Index: 1
#2Annelieke PasmaH-Index: 6
Last. Marijn VisH-Index: 17
view all 8 authors...
Source
Background: null Information on adverse drug reactions (ADRs) is generally clustered for all indications of a drug in the patient information leaflet. However, previous research has shown that participants of the Dutch Biologic Monitor (DBM) that use a biologic for their immune-mediated inflammatory disease (IMID) prefer to receive ADR information tailored to their own biologic an IMID (1). Currently, it is unclear whether the ADR profile of a specific biologic may differ between patients with d...
Source
Source
Source
#1J. Van LintH-Index: 1
#2Naomi T. JessurunH-Index: 6
Last. Harald E. Vonkeman (Medisch Spectrum Twente)H-Index: 26
view all 11 authors...
Background: Although an increased risk of inflammatory bowel disease (IBD) during etanercept (ETN) use is included in the product information of ETN, no other gastro-intestinal (GI-)adverse drug reactions (ADRs) are described. This is in contrast with other TNFα-inhibitors such as adalimumab (ADA) and infliximab, as these are associated with various GI-ADRs such as nausea and abdominal pain. Objectives: To identify the proportion and type of patient-reported and health care professional (HCP)-re...
Source
Background: Chronic fatigue is a well-known symptom in patients with rheumatic diseases and other immune-mediated inflammatory diseases (IMIDs). Therefore, fatigue as an adverse drug reaction (ADR) to biologics may remain unrecognised or may erroneously be attributed to the disease. Objectives: To assess patient-reported fatigue attributed to biologics for IMIDs and investigate predisposing factors of patient-reported fatigue. Methods: The Dutch Biologic Monitor is a multicenter patient-reported...
Source
Background: Patient-reported outcomes (PROs) are increasingly used in studies and medical practice to obtain information on patients’ perspectives towards their treatment or disease. However, study outcomes are primarily directed at and shared with healthcare professionals, even though the results may also be relevant for patients. Objectives: The objective of this study was to obtain insight in which results patients with immune-mediated inflammatory diseases (IMIDs), including inflammatory rhe...
Source
#1D. Wang (EUR: Erasmus University Rotterdam)
#2Jeffrey Damman (EUR: Erasmus University Rotterdam)H-Index: 7
Last. M.B.A. van Doorn (EUR: Erasmus University Rotterdam)H-Index: 7
view all 3 authors...
: A 28-year-old woman was seen at our clinic with asymptomatic bumps in the eyebrows which arose 3 months after microblading, a cosmetic procedure to make the eyebrows appear fuller. Physical examination showed red-brown confluent papules. A skin biopsy revealed a non-necrotizing granulomatous reaction with sarcoid granulomas. Blood test and a chest X-ray showed no abnormalities and histopathological stains were negative. We diagnosed her with a granulomatous reaction in response to pigment. The...
This website uses cookies.
We use cookies to improve your online experience. By continuing to use our website we assume you agree to the placement of these cookies.
To learn more, you can find in our Privacy Policy.